Jordi Mestres is the head of the Systems Pharmacology group of the IMIM-UPF joint Research Programme on Biomedical Informatics (GRIB) and associate professor at the Universitat Pompeu Fabra (UPF, Spain). He holds a PhD in Computational Chemistry from the University of Girona (Spain). After a post-doctoral stay at Pharmacia&Upjohn (Kalamazoo, Michigan, USA), in 1997 he joined the Molecular Design & Informatics department at N.V. Organon (Oss, The Netherlands) and in 2000 he was appointed Head of Computational Medicinal Chemistry at Organon Laboratories (Newhouse, Scotland, UK). In 2003, he took on his current position as Head of the Systems Pharmacology group of GRIB. In March 2006, he founded Chemotargets as a spin-off company of his group. He is the author of over 160 publications, 8 patents among them, and main responsible of numerous research projects in collaboration with public and private institutions. He developed numerous scientific software of widespread use in pharmaceutical companies and academic centres (Pharmatrek, Visca, iPHACE and others).
His research interests focus on the use and development of computational approaches to integrate chemical, biological, and phenotypic spaces and their application to systems chemical biology and drug discovery.